申请人:MITSUI PHARMACEUTICALS, INC.
公开号:EP0305184A1
公开(公告)日:1989-03-01
Compounds of formula
where X is -NR¹R² or SR⁴; Y is amino optionally substituted by alkyl; Z is methyl substituted by alkoxy carbonyl or alkoxycarbonyl or Y and Z together may form a divalent group -X-Y- of formula
. The compounds are useful in the treatment if neurological diseases of the pheripheral and central nervous systems of animals.
式中化合物
其中 X 是-NR¹R²或 SR⁴;Y 是任选被烷基取代的氨基;Z 是被烷氧羰基或烷氧羰基取代的甲基,或 Y 和 Z 可共同形成式中的二价基团-X-Y-。
.这些化合物可用于治疗动物外周和中枢神经系统的神经疾病。